pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma
Chinese Academy of
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chinese Academy of clinical programs — 207 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- China, TAIZHOU, CN
- Employees
- 170
- Programs
- 1328
- Drugs
- 711
- Patents
- 335
Chinese Academy of projects
207 ClinicalTrials.gov programs sponsored by Chinese Academy of.
Chinese Academy of has 207 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Dexmedetomidine Injectable Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
EUS-guided pancreatic pseudocyst drainage
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatic Pseudocyst
1 trial -
EV71 Vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hand, Foot and Mouth Disease
1 trial -
Echocardiographic guidance
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aortic Stenosis
1 trial -
Edaravone Dexborneol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chemo Brain
1 trial -
Edoxaban
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Valvular Atrial Fibrillation
1 trial -
Eldecalcitol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoporosis in Postmenopausal Women
1 trial -
Empagliflozin 10 MG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pre-Heart Failure
1 trial -
Enhanced dermatologic management
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC (Advanced Non-small Cell Lung Cancer)
1 trial -
Entecavir+Fuzheng Huayu+TCM Granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Virus Related Cirrhosis
1 trial -
Entecavir, Adefovir
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Epirubicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carcinoma, Hepatocellular
1 trial -
Etoposide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mantle Cell Lymphoma
1 trial -
Exenatide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
Ferric derisomaltose
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Heart Failure With Reduced Ejection Fraction
1 trial -
Ferric derisomaltose
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Heart Failure With Preserved Ejection Fraction
1 trial -
Fespixon Cream
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Foot Ulcer (DFU)
1 trial -
Fluoxetine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depressive Disorder
1 trial -
FuKe Qianjin Capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Endometritis
1 trial -
Glycopyrronium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Nausea and Vomiting
1 trial -
Group A (the standard 2HRZE/4HR regimen)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
1 trial -
Guilingji Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oligospermia
1 trial -
Guli capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Hemodialysis with Polymethylmethacrylate Artificial Kidney
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uremia
1 trial -
ICS+LABA
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis
1 trial -
Imipenem
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Inactivated COVID-19 vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Inactivated Polio Vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Vaccination
1 trial -
Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2 Infection
1 trial -
Insulin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatitis, Acute
1 trial -
Intensive statin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
Isoniazid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis, Pulmonary
1 trial -
Isoniazid Aminosalicylate Tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Reinfection Pulmonary Tuberculosis
1 trial -
Jejunostomy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
K9520
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
Kanglaite Injection+Chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC
1 trial -
LABA/LAMA or Placebo inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis Adult
1 trial -
Ledipasvir 90mg/Sofosbuvir 400 mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
Lithium Carbonate 250 MG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sleep Deprivation
1 trial -
Low-Molecular-Weight Heparins Calcium Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pneumonia
1 trial -
MIYAIRI 588
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression Mild
1 trial -
Measles-Rubella combined vaccine(MR)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Measles
1 trial -
Methylprednisolone and Mycophenolate mofetil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hepatitis
1 trial -
Metronidazole vaginal suppositories
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bacterial Vaginosis
1 trial -
Micafungin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aspergillosis
1 trial -
Mifepristone tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uterine Fibroid
1 trial -
Misoprostol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Labor
1 trial
Frequently asked questions
How many clinical projects does Chinese Academy of have?
207 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.